arrow
J

Joachim Alexandre

normandie university
H指数:31
被引数:6,862

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study

肾素-血管紧张素系统与伊布替尼相关心血管不良事件的关系:一项转化队列研究

2025-09-060
OA
Immune checkpoint inhibitor-associated myocarditis: a novel risk score

免疫检查点抑制剂相关心肌炎:一种新型风险评分

2025-06-180
PRE
Risk of thyroid cancer related to glucagon-like peptide-1 receptor agonists: A systematic review with meta-analysis of harms of randomized controlled trials

与胰高血糖素样肽-1受体激动剂相关的甲状腺癌风险:一项关于随机对照试验危害的系统评价与荟萃分析

2025-06-050
PRE
Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis

识别与癌症治疗相关心脏功能障碍相关的抗癌药物:一项VigiBase®成比例差异分析

2025-04-240
PRE
Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials

通过模拟CA-125 KELIM评估肿瘤原发性化疗敏感性,以预测接受新辅助化疗和免疫治疗治疗的卵巢癌患者完全间隔减瘤术(IDS)的作用:一项GINEGEPS/GINECO研究,来自NeoPembrOv和INeOV试验

2024-09-010
PRE
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
2024-01-032
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (oct, 10.1038/s41591-023-02591-2, 2023)
2023-11-270
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
2023-10-2622
PRE